Any feedback?
Literature summary for 3.4.22.B30 extracted from
- Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle (2005), Diabetes, 54, 3015-3020.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| intralipid | fat emulsion consisting of 12% palmitic acid, 4% stearic acid, 21% oleic acid, 53% linoleic acid, 7% alpha-linoleic acid, and 3% other acids, after 24 h exposure, increase in CAPN10 mRNA in response to insulin in subjects with normal glucose tolerance | Homo sapiens |
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | glucose-tolerant but not glucose-intolerant individuals upregulate their CAPN10 mRNA levels in response to prolonged exposure to fat | Homo sapiens |
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
- |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | Q9HC96 | - |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| skeletal muscle | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| calpain-10 | - |
Homo sapiens |
| CAPN10 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
